PFE logo

Pfizer Inc. (PFE)

$28.47

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on PFE

Market cap

$162.27B

EPS

0.7

P/E ratio

37.2

Price to sales

2.53

Dividend yield

6.041%

Beta

0.306826

Price on PFE

Previous close

$28.86

Today's open

$28.48

Day's range

$28.35 - $28.67

52 week range

$23.62 - $31.44

Profile about PFE

CEO

Albert Bourla

Employees

75000

Headquarters

New York, NY

Exchange

New York Stock Exchange

Shares outstanding

5.70B

Issue type

Common Stock

PFE industries and sectors

Healthcare

Pharmaceuticals

News on PFE

Pfizer Enters into Exclusive Licensing Agreement with Starna Therapeutics for Autoimmune Diseases

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that it entered into an exclusive licensing agreement with Starna Therapeutics, a biotechnology company developing RNA medicines designed to enable in vivo therapeutics. Under the agreement, Pfizer obtains exclusive rights outside Greater China to develop, manufacture and commercialize three pre-IND in vivo chimeric antigen receptor T-cell (CAR-T) programs that are focused on treating autoimmune diseases. Pfizer also receives ri.

news source

Business Wire • 14 hours ago

news preview

3 High-Yield Dividend Stocks Down Nearly 30% or More in 5 Years

Three famous dividend payers have lost a big chunk of their value since 2020, and two already slashed their payouts. Before chasing the fat yields, income investors should ask which of these beaten-down stocks still has a dividend worth trusting.

news source

24/7 Wall Street • 12 hours ago

news preview

Pfizer: Strong Growth Momentum And Attractive Valuation Support A Strong Buy

Pfizer remains a Strong Buy: improved gross margin, accelerating launched and acquired products, and raised guidance support the thesis. Q3 revenue reached $16.58B, beating by $700M; launched and acquired products grew 32%, while gross margin improved to about 77%. PFE raised FY26 revenue guidance to $62B–$64B and adjusted EPS guidance to $2.95–$3.05; implied Q4 expectations still look conservative.

news source

Seeking Alpha • 19 hours ago

news preview

Pfizer: The Patent Cliff Fears Are Overblown

Pfizer Inc., a Big Pharma player offering a 5.96% dividend yield, remains a controversial choice among long-term retail investors. Most concerns reflect PFE's upcoming patent expiration cycle, which is expected to last about 3 years. However, I believe these fears are overblown given PFE's oncology portfolio, Eliquis, and tafamidis franchise, which delivered strong Q3 performance.

news source

Seeking Alpha • 11 hours ago

news preview

Pfizer CEO Sees Growth Beyond Patent Cliff, Highlights Monthly Obesity Drug Ambitions

Pfizer NYSE: PFE expects recently launched medicines and a growing pipeline to help it emerge from a period of patent expirations with high single-digit growth, CEO Albert Bourla said at the Jefferies London Healthcare Conference.

news source

MarketBeat • Nov 17, 2026

news preview

Pfizer Inc. (PFE) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Pfizer Inc. (PFE) Presents at Jefferies Global Healthcare Conference 2026 Transcript

news source

Seeking Alpha • Nov 17, 2026

news preview

5 Huge Dividend Payers the IRS Leaves Alone Inside a Roth

Two investors can own the same five blue chip dividend stocks and keep different amounts of income. When held outside a tax-advantaged account, every payment is taxed the year it arrives.

news source

24/7 Wall Street • Nov 17, 2026

news preview

5 “Forever Income” Dividend Stocks Yielding 5% and More for Boomers

If you're retired and living off a portfolio, a dividend has two jobs. It has to pay enough to matter, and it has to keep paying through a full market cycle.

news source

24/7 Wall Street • Nov 17, 2026

news preview

5 Safe High-Yield Dividend Stocks Boomers Should Buy Before Year-End

Retirees heading into year-end need income that holds up through a recession, a rate shift or a bad quarter, so a high yield alone isn't enough. These five US-listed payers come from five different sectors (telecom, real estate, asset management, pharma and tobacco).

news source

24/7 Wall Street • Nov 17, 2026

news preview

Wall Street Forgot These 3 Dividend Stocks — Now They Pay Over 5%

Income investors tend to crowd into whatever is popular, leaving solid payers ignored. The three stocks below are in health care, telecom, and financials.

news source

24/7 Wall Street • Nov 17, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Pfizer Inc.

Open an M1 investment account to buy and sell Pfizer Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in PFE on M1